01 March 2006
Trustworthy alteration and improvement in adjuvant treatment of colon cancer.
Ali Harlak, Atilla SoranMed Sci Monit 2006; 12(3): RA46-52 :: ID: 447119
Abstract
Colorectal cancer is the third most common cancer both in men and womenin the United States. Advances in adjuvant treatment of colon cancer have came to consist of a successionof small improvements by large-scale clinical trials. The National Surgical Adjuvant Breast and BowelProject (NSABP) colon trials reflect the exciting history of progress in adjuvant treatment of coloncancer. Since 1977, the NSABP has successfully designed and conducted seven large-scale prospective randomizedclinical trials for colon cancers that has altered and improved the standard of care for patients withthis disease. More than 5,000 physicians, nurses, and other medical professionals at nearly 200 medicalsites from across the United States, Canada, Puerto Rico, Australia and New Zealand assist the NSABPin its mission to eliminate colorectal and breast cancers. These medical sites include several universityhospitals and many other local medical centers that treat patients from a variety of social, and economicbackgrounds contributed to the trials. The NSABP clinical trials are distinctive because of the largenumber of patients and elimination of social, cultural and economic influences. The ongoing trials ofthe NSABP should continue to provide information used to determine principals of neoadjuvant treatmentfor colon cancer. In this article we review seven prospective randomized clinical trials with their publishedresults and discuss the combined analysis of the first four trials.
Keywords: Clinical Trials as Topic, Chemotherapy, Adjuvant - statistics & numerical data, Colonic Neoplasms - therapy, Combined Modality Therapy, Disease-Free Survival, Follow-Up Studies, Time Factors
Editorial
01 April 2024 : Editorial
Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug ResistanceDOI: 10.12659/MSM.944600
Med Sci Monit 2024; 30:e944600
In Press
06 Mar 2024 : Clinical Research
Comparison of Outcomes between Single-Level and Double-Level Corpectomy in Thoracolumbar Reconstruction: A ...Med Sci Monit In Press; DOI: 10.12659/MSM.943797
21 Mar 2024 : Meta-Analysis
Economic Evaluation of COVID-19 Screening Tests and Surveillance Strategies in Low-Income, Middle-Income, a...Med Sci Monit In Press; DOI: 10.12659/MSM.943863
10 Apr 2024 : Clinical Research
Predicting Acute Cardiovascular Complications in COVID-19: Insights from a Specialized Cardiac Referral Dep...Med Sci Monit In Press; DOI: 10.12659/MSM.942612
06 Mar 2024 : Clinical Research
Enhanced Surgical Outcomes of Popliteal Cyst Excision: A Retrospective Study Comparing Arthroscopic Debride...Med Sci Monit In Press; DOI: 10.12659/MSM.941102
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952